What You Should Know:
– Linea, a post-acute care platform backed by founding investor Redesign Health and DaVita, announced the continued expansion of its heart failure care solution.
– The Linea platform delivers a 90-day AI-powered program for heart failure patients that has demonstrated a remarkable 50% reduction in hospital readmissions, sustained patient engagement, and meaningful cost savings for Accountable Care Organizations (ACOs).
Driving Measurable Impact and Value-Based Outcomes
Each year, more than 4 million Americans are hospitalized for heart failure, with 40% readmitted to the hospital within 90 days. These largely preventable readmissions place heavy burdens on patients and their loved ones, providers, and health systems. Linea tackles this challenge by combining generative AI-powered hospital admission detection, protocolized prescribing and dosing optimization, and real-time patient engagement into a single, scalable model that improves care consistency and quality.
Linea’s solution is offered at no cost to patients and utilizes a value-based pricing model where ACOs pay only for actively enrolled patients, which helps partners control costs and earn shared savings.
Early results from the platform show a strong impact:
- Readmission Rate: Linea’s 90-day readmission rate is under 25%, well below the national average of 40%.
- Patient Engagement: On average, patients engage in the platform within 2 days of a health event, with nearly 80% of patients engaged before being discharged from the hospital.
- Early Intervention: The Linea platform identifies patient admissions and hospital discharges 4 days earlier than traditional methods, giving care teams a critical head start.
- Proactive Support: Patients receive more than a dozen supportive calls and messages in the first 30 days post-hospitalization, a stark contrast to the national norm where 60% of patients receive no follow-up at all.
By shifting from labor-intensive outreach to intelligent automation, Linea enables care teams to scale patient engagement without scaling cost, redefining what’s possible in value-based care.
